Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Synthesis of sialyl Lewisa (sLea, CA19-9) and construction of an immunogenic sLea vaccineCancer Immunology, Immunotherapy, 2009
- Intrahepatic CholangiocarcinomaAnnals of Surgery, 2008
- Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy for Gallbladder CancerJournal of Clinical Oncology, 2008
- The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancerSurgery, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Role of three-dimensional imaging in operative planning for hilar cholangiocarcinomaSurgery, 2007
- Preoperative Carbohydrate Antigen 19-9 is Most Predictive of Malignancy in Older Jaundiced Patients Undergoing Pancreatic ResectionPancreas, 2006
- Current approaches to the diagnosis and treatment of cholangiocarcinomaCurrent Gastroenterology Reports, 2006
- Biliary tract cancers: current concepts and controversiesExpert Opinion on Pharmacotherapy, 2005
- The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitisAmerican Journal of Gastroenterology, 2000